bf/NASDAQ:ANIK_icon.jpeg

NASDAQ:ANIK

Anika Therapeutics, Inc.

  • Stock

USD

Last Close

28.31

26/07 20:00

Market Cap

389.26M

Beta: 0.83

Volume Today

37.54K

Avg: 81.01K

PE Ratio

−14.02

PFCF: −31.16

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
75.08M
-
105.59M
40.64%
93.00M
11.93%
103.38M
11.16%
113.42M
9.71%
105.56M
6.93%
114.61M
8.58%
130.46M
13.83%
147.79M
13.29%
156.24M
5.71%
166.66M
6.67%
cost of revenue
22.77M
-
20.93M
8.06%
21.05M
0.59%
24.03M
14.13%
27.36M
13.89%
31.28M
14.31%
28.75M
8.10%
61.43M
113.70%
64.85M
5.57%
62.66M
3.38%
63.57M
1.46%
gross profit
52.32M
-
84.66M
61.83%
71.95M
15.02%
79.35M
10.29%
86.06M
8.45%
74.28M
13.69%
85.86M
15.60%
69.03M
19.61%
82.94M
20.16%
93.58M
12.82%
103.09M
10.16%
selling and marketing expenses
general and administrative expenses
12.94M
-
15.07M
16.52%
14.82M
1.65%
18.01M
21.50%
21.54M
19.58%
34.34M
59.41%
selling general and administrative expenses
12.94M
-
15.07M
16.52%
14.82M
1.65%
18.01M
21.50%
21.54M
19.58%
34.34M
59.41%
34.95M
1.79%
60.06M
71.85%
74.10M
23.36%
84.79M
14.44%
95.85M
13.04%
research and development expenses
7.06M
-
8.14M
15.36%
8.99M
10.35%
10.73M
19.42%
18.79M
75.06%
18.19M
3.18%
16.66M
8.38%
23.43M
40.60%
27.33M
16.63%
28.18M
3.13%
32.69M
16.00%
other expenses
cost and expenses
42.76M
-
44.15M
3.24%
44.87M
1.62%
52.77M
17.62%
67.69M
28.27%
83.81M
23.81%
80.36M
4.11%
144.93M
80.34%
166.27M
14.73%
175.64M
5.63%
192.11M
9.38%
operating expenses
20.00M
-
23.22M
16.11%
23.81M
2.56%
28.75M
20.72%
40.33M
40.29%
52.53M
30.25%
51.62M
1.73%
83.49M
61.76%
101.42M
21.47%
112.98M
11.39%
128.54M
13.77%
interest expense
-446.50K
-
-58.14K
86.98%
-120K
106.41%
-263K
119.17%
-473K
79.85%
-1.46M
208.25%
-302K
-
-188K
37.75%
654K
447.87%
2.31M
253.52%
ebitda
32.03M
-
61.45M
91.82%
48.13M
21.67%
50.61M
5.14%
45.73M
9.64%
21.75M
52.44%
34.25M
57.47%
-614K
101.79%
-39.58M
6,345.44%
-19.40M
50.98%
-11.21M
42.19%
operating income
32.61M
-
61.45M
88.45%
48.13M
21.67%
50.61M
5.14%
45.73M
9.64%
21.75M
52.44%
34.25M
57.47%
-14.47M
142.24%
-18.48M
27.73%
-19.40M
4.98%
-25.45M
31.18%
depreciation and amortization
4.77M
-
4.71M
1.40%
3.77M
19.78%
3.73M
1.09%
4.29M
14.89%
5.91M
37.76%
5.99M
1.37%
13.85M
131.25%
-21.09M
252.27%
14.49M
168.68%
14.23M
1.75%
total other income expenses net
286.84K
-
58.14K
79.73%
120K
106.41%
263K
119.17%
473K
79.85%
1.46M
208.25%
1.87M
28.46%
-14.16M
855.79%
20.91M
247.69%
654K
96.87%
-59.88M
9,255.66%
income before tax
32.48M
-
61.51M
89.37%
48.25M
21.54%
50.87M
5.42%
46.20M
9.18%
23.21M
49.77%
36.12M
55.65%
-28.62M
179.24%
2.43M
108.48%
-18.75M
872.39%
-85.33M
355.17%
income tax expense
11.91M
-
23.19M
94.75%
17.50M
24.54%
18.32M
4.73%
14.39M
21.49%
4.49M
68.82%
8.93M
99.06%
-4.64M
151.99%
-1.71M
63.23%
-3.89M
127.71%
-2.66M
31.57%
net income
20.57M
-
38.32M
86.25%
30.76M
19.73%
32.55M
5.82%
31.82M
2.25%
18.72M
41.16%
27.19M
45.25%
-23.98M
188.19%
4.13M
117.24%
-14.86M
459.43%
-82.67M
456.34%
weighted average shs out
14.09M
-
14.68M
4.20%
14.93M
1.74%
14.68M
1.69%
14.57M
0.73%
14.44M
0.91%
14.12M
2.22%
14.22M
0.72%
14.40M
1.26%
14.56M
1.11%
14.66M
0.65%
weighted average shs out dil
14.83M
-
15.27M
2.99%
15.32M
0.34%
15.12M
1.34%
15.07M
0.32%
14.69M
2.52%
14.37M
2.14%
14.22M
1.06%
14.63M
2.90%
14.56M
0.50%
14.66M
0.65%
eps
1.46
-
2.61
78.77%
2.06
21.07%
2.22
7.77%
2.18
1.80%
1.30
40.37%
1.93
48.46%
-1.69
187.56%
0.29
117.16%
-1.02
451.72%
-5.64
452.94%
epsdiluted
1.39
-
2.51
80.58%
2.01
19.92%
2.15
6.97%
2.11
1.86%
1.27
39.81%
1.89
48.82%
-1.69
189.42%
0.28
116.57%
-1.02
464.29%
-5.64
452.94%

All numbers in USD (except ratios and percentages)